Clinical Trials Directory

Trials / Conditions / GEP-NET

GEP-NET

8 registered clinical trials studyying GEP-NET — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
NCT07165132
RayzeBio, Inc.Phase 1
Enrolling By InvitationNal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
NCT05385861
National Health Research Institutes, TaiwanPhase 1 / Phase 2
RecruitingInfluence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated
NCT06356467
IRCCS San Raffaele—
RecruitingObservational Study on GEP-and Pulm-NET Treated at FPG
NCT06402695
Fondazione Policlinico Universitario Agostino Gemelli IRCCS—
UnknownDual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
NCT05709171
Rigshospitalet, DenmarkPhase 2
TerminatedA Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participan
NCT05364944
Debiopharm International SAPhase 1
Unknown68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET
NCT05448157
European Institute of Oncology—
RecruitingStudy of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Fo
NCT05477576
RayzeBio, Inc.Phase 3